Demetrix
ID: 5313318Demetrix is a biotechnology company that uses genes found in natural medicines and introduces them to domesticated microbes, for example, the synthetic production of certain chemicals. Demetrix was founded by Dr Haseltine and Jay Keasling.
2
Funding Rounds
$61.0m
Money raised
Recent Funding Rounds
Overview
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja* Ke****** |
|
- | |
| Wi***** Ha******* | - | - | linkedin twitter |
Funding series
Funding Series Analysis
The company Demetrix has raised a total of $50m in funding over 2 rounds.
Key Insights:
- Demetrix Series A round, July 2019: $50m
- Demetrix Seed round, September 2017: $11m